Entry46.52→Now48.65
Buy ARKG for biotech cycle. Open original source
Price change since each call, adjusted for long/short direction. Results calculated:
Across the available history and selected sources, Buzzberg tracks ARKG (ARK Genomic Revolution ETF) across 18 sources: 35 bullish vs 1 bearish calls from 14 authors. Historical directional balance: 55% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 62 total trade ideas tracked. Past 7 days, before deduplication: 2 bullish, 3 other directions. Latest voices: Alexander Good, Park Se-ik, wliang.